首页> 外文期刊>Angewandte Chemie >Selective Degradation of Polo-like Kinase 1 by a Hydrophobically Tagged Inhibitor of the Polo-Box Domain
【24h】

Selective Degradation of Polo-like Kinase 1 by a Hydrophobically Tagged Inhibitor of the Polo-Box Domain

机译:通过疏水标记的Polo-Box结构域的疏水标记抑制剂选择性降解Polo样激酶1

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hydrophobic tagging (HT) of bioactive compounds can induce target degradation via the proteasomal pathway. The first application of hydrophobic tagging to an existing inhibitor of protein-protein interactions is now presented. We developed Poloxin-2HT by fusing an adamantyl tag to Poloxin-2, an inhibitor of the polo-box domain of the protein kinase Plk1, which is a target for tumor therapy. Poloxin-2HT selectively reduced the protein levels of Plk1 in HeLa cells and had a significantly stronger effect on cell viability and the induction of apoptosis than the untagged PBD inhibitor Poloxin-2. The change in cellular phenotype associated with the addition of the hydrophobic tag to Poloxin-2 demonstrated that Poloxin-2HT targets Plk1 in living cells. Our data validate hydrophobic tagging of selective inhibitors of protein-protein interactions as a novel strategy to target and destroy disease-relevant proteins.
机译:生物活性化合物的疏水标记(HT)可以通过蛋白酶体途径诱导目标降解。 现在呈现疏水标记对现有的蛋白质 - 蛋白质相互作用抑制剂的第一次施用。 我们通过将蛋白质-2熔化为脊髓素-2,蛋白激酶PLK1的蛋白质激酶结构域的抑制剂,开发了晶片-2HT,这是肿瘤治疗的靶标。 泊氏-2HT在HeLa细胞中选择性地降低了PLK1的蛋白质水平,对细胞活力的显着效果明显较强,凋亡诱导多于未标记的PBD抑制剂脊髓苷-2。 将疏水标签添加到脊键-2的蜂窝状表型的变化证明了活细胞中的脊氏-2HT靶向PLK1。 我们的数据验证了蛋白质 - 蛋白质相互作用选择性抑制剂的疏水标记,作为靶向和破坏疾病相关蛋白的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号